MedPath

Comparison of intravenous, local and oral Tranexamic Acid effect on reducing postoperative bleeding ?in coronary artery bypass graft surgery

Phase 3
Recruiting
Conditions
Coronary artery bypass graft surgery.
Mechanical complication of coronary artery bypass graft and biological heart valve graft
T82.2
Registration Number
IRCT20141209020258N166
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
96
Inclusion Criteria

All elective patients are candidates for coronary artery bypass graft surgery
Lack of sensitivity to Tranexamic Acid

Exclusion Criteria

Death of patients
Reluctance to participate in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding. Timepoint: Within 24 hours. Method of measurement: Observation.;Count of platelet received. Timepoint: Within 24 hours. Method of measurement: Count.;Number of fresh frozen plasma received. Timepoint: Within 24 hours. Method of measurement: Count.;Number of pack cell received. Timepoint: Within 24 hours. Method of measurement: Count.;Mortality. Timepoint: Within 72 hours. Method of measurement: Observation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath